Top Markets
#1 NEW X CEO IS BACK NEW X CEO IS BACK +210,975.57%
#2 Beta Finance Beta Finance +8,979.03%
#3 Tribe Tribe +73.83%
#4 Orochi Network Orochi Network +53.40%
#5 Chainbase Chainbase +40.85%
#6 BabyBoomToken BabyBoomToken +34.25%
#7 Block Street Block Street +31.59%
#8 Chrema Coin Chrema Coin +28.62%
#9 Freysa AI Freysa AI +26.78%
#10 B3 (Base) B3 (Base) +25.98%
Coin of the day
NEW X CEO IS BACK NEW X CEO IS BACK
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Nuformix plc Nuformix plc

Nuformix plc

NFX
शेयरों में रैंक #20651
Nuformix plc operates in the field of pharmaceutical development for treating... Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
शेयर मूल्य
$0.00244926
मार्केट कैप
$51.67K
बदलाव (1 दिन)
5.88%
बदलाव (1 वर्ष)
110.15%
देश
GB
व्यापार Nuformix plc (NFX)

श्रेणी

Healthcare
Nuformix plc (NFX) के लिए कमाई
Sep 2025 में कमाई TTM: $-5.28M
Nuformix plc की नवीनतम वित्तीय रिपोर्टों के अनुसार, कंपनी की वर्तमान कमाई $-5.28M है। 2024 में कंपनी ने $-4.88M की कमाई की, जो 2023 की कमाई $-754.56K के की तुलना में कमी है। इस पृष्ठ पर दिखाई गई कमाई ब्याज और कर से पहले की कमाई है, जिसे EBIT कहा जाता है।
Nuformix plc के लिए कमाई का इतिहास 2014 से 2026 तक
प्रत्येक वर्ष के अंत में कमाई
वर्ष कमाई परिवर्तन
2026 (TTM) $-5.28M 494.63%
2025 $-888.01K -81.80%
2024 $-4.88M 546.72%
2023 $-754.56K -54.82%
2022 $-1.67M -11.94%
2021 $-1.90M 64.37%
2020 $-1.15M -51.92%
2019 $-2.40M -12.87%
2018 $-2.75M 220.48%
2017 $-859.40K 70.68%
2016 $-503.51K -206.04%
2014 $474.83K 0.00%
समान कंपनियों या प्रतियोगियों की कमाई
कंपनी कमाई कमाई में अंतर देश
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
$20.46B -387,521.89%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$4.64B -88,033.93%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
$5.23B -99,160.13%
US
UCB SA UCB SA
UCB SA
UCB.BR
$2.14B -40,584.12%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -30,671.66%
AU